| Enzalutamide in metastatic prostate cancer before chemotherapy TM Beer, AJ Armstrong, DE Rathkopf, Y Loriot, CN Sternberg, CS Higano, ... New England Journal of Medicine 371 (5), 424-433, 2014 | 3544 | 2014 |
| Management of patients with advanced prostate cancer: the report of the Advanced Prostate Cancer Consensus Conference APCCC 2017 S Gillessen, G Attard, TM Beer, H Beltran, A Bossi, R Bristow, B Carver, ... European urology 73 (2), 178-211, 2018 | 895* | 2018 |
| Human polymorphism at microRNAs and microRNA target sites MA Saunders, H Liang, WH Li Proceedings of the National Academy of Sciences 104 (9), 3300-3305, 2007 | 796 | 2007 |
| lncRNA-dependent mechanisms of androgen-receptor-regulated gene activation programs L Yang, C Lin, C Jin, JC Yang, B Tanasa, W Li, D Merkurjev, KA Ohgi, ... Nature 500 (7464), 598-602, 2013 | 774 | 2013 |
| Genomic hallmarks and structural variation in metastatic prostate cancer DA Quigley, HX Dang, SG Zhao, P Lloyd, R Aggarwal, JJ Alumkal, A Foye, ... Cell 174 (3), 758-769. e9, 2018 | 727 | 2018 |
| Mechanisms of resistance in castration-resistant prostate cancer (CRPC) T Chandrasekar, JC Yang, AC Gao, CP Evans Translational andrology and urology 4 (3), 365, 2015 | 727 | 2015 |
| Clinical and genomic characterization of treatment-emergent small-cell neuroendocrine prostate cancer: a multi-institutional prospective study R Aggarwal, J Huang, JJ Alumkal, L Zhang, FY Feng, GV Thomas, ... Journal of Clinical Oncology 36 (24), 2492-2503, 2018 | 705 | 2018 |
| An androgen-regulated miRNA suppresses Bak1 expression and induces androgen-independent growth of prostate cancer cells XB Shi, L Xue, J Yang, AH Ma, J Zhao, M Xu, CG Tepper, CP Evans, ... Proceedings of the National Academy of Sciences 104 (50), 19983-19988, 2007 | 598 | 2007 |
| MicroRNA in prostate, bladder, and kidney cancer: a systematic review JWF Catto, A Alcaraz, AS Bjartell, RDV White, CP Evans, S Fussel, ... European urology 59 (5), 671-681, 2011 | 568 | 2011 |
| Enzalutamide in men with chemotherapy-naive metastatic castration-resistant prostate cancer: extended analysis of the phase 3 PREVAIL study TM Beer, AJ Armstrong, D Rathkopf, Y Loriot, CN Sternberg, CS Higano, ... European urology 71 (2), 151-154, 2017 | 501 | 2017 |
| Contesting citizenship: Irregular migrants and new frontiers of the political A McNevin Columbia University Press, 2011 | 457 | 2011 |
| Concordance of circulating tumor DNA and matched metastatic tissue biopsy in prostate cancer AW Wyatt, M Annala, R Aggarwal, K Beja, F Feng, J Youngren, A Foye, ... JNCI: Journal of the National Cancer Institute 109 (12), djx118, 2017 | 412 | 2017 |
| Niclosamide inhibits androgen receptor variants expression and overcomes enzalutamide resistance in castration-resistant prostate cancer C Liu, W Lou, Y Zhu, N Nadiminty, CT Schwartz, CP Evans, AC Gao Clinical cancer research 20 (12), 3198-3210, 2014 | 371 | 2014 |
| Understanding the mechanisms of androgen deprivation resistance in prostate cancer at the molecular level T Karantanos, CP Evans, B Tombal, TC Thompson, R Montironi, ... European urology 67 (3), 470-479, 2015 | 337 | 2015 |
| Cervical HPV infection and neoplasia in a large population-based prospective study: the Manchester cohort J Peto, C Gilham, J Deacon, C Taylor, C Evans, W Binns, M Haywood, ... British journal of cancer 91 (5), 942-953, 2004 | 334 | 2004 |
| Preexposure prophylaxis for the prevention of HIV infection: evidence report and systematic review for the US Preventive Services Task Force R Chou, C Evans, A Hoverman, C Sun, T Dana, C Bougatsos, S Grusing, ... Jama 321 (22), 2214-2230, 2019 | 298 | 2019 |
| Histopathology of surgically treated renal cell carcinoma: survival differences by subtype and stage KA Keegan, CW Schupp, K Chamie, NJ Hellenthal, CP Evans, TM Koppie The Journal of urology 188 (2), 391-397, 2012 | 289 | 2012 |
| The DNA methylation landscape of advanced prostate cancer SG Zhao, WS Chen, H Li, A Foye, M Zhang, M Sjöström, R Aggarwal, ... Nature genetics 52 (8), 778-789, 2020 | 282 | 2020 |
| Genomic markers in prostate cancer decision making V Cucchiara, MR Cooperberg, M Dall’Era, DW Lin, F Montorsi, ... European urology 73 (4), 572-582, 2018 | 277 | 2018 |
| Intracrine androgens and AKR1C3 activation confer resistance to enzalutamide in prostate cancer C Liu, W Lou, Y Zhu, JC Yang, N Nadiminty, NW Gaikwad, CP Evans, ... Cancer research 75 (7), 1413-1422, 2015 | 269 | 2015 |
